Tesla has postponed the U.S. launch of a low-cost version of its best-selling electric SUV, the Model Y, internally codenamed E41, according to sources cited by Reuters. Production of this affordable EV, originally expected in the first half of 2025, may now start between Q3 and early 2026. The exact reason for the delay remains unclear.
Tesla had promised a lineup of budget-friendly electric vehicles to reignite sales and attract new buyers. The new Model Y is designed to be smaller and 20% cheaper to produce than the refreshed version, which currently starts at around $49,000 before a $7,500 U.S. federal tax credit. Two sources said Tesla aims to manufacture 250,000 of the budget Model Y units in the U.S. by 2026, with future plans to expand production to China and Europe.
The EV giant also plans to introduce a stripped-down Model 3, further targeting the mass market. However, no comment has been provided by Tesla on the revised timelines or production targets.
Tesla’s delay comes amid declining EV sales, intensified by aging vehicle models and growing competition. The company reported its first annual drop in deliveries on January 2, and analysts predict further sales decline due to reputational damage tied to CEO Elon Musk’s political alliances and the lack of lower-priced models.
Elon Musk had previously teased a $25,000 EV platform but shifted focus to autonomous robotaxis. Meanwhile, Tesla is boosting North American parts sourcing to reduce tariff exposure, following the imposition of 25% tariffs by President Trump. This has already affected plans to import Cybercab and Semi components from China.
As Tesla prepares to report earnings, investors await clarity on affordable EVs, a critical move to regain momentum in a rapidly evolving electric vehicle market.


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



